Sleep Disorders Pharmaceutical and Healthcare Pipeline Review 2017

Pune, India, 13th October 2017: WiseGuyReports announced addition of new report, titled “Sleep Disorders Drug Development Pipeline Review, 2017”.

Pune, India - October 13, 2017 /MarketersMedia/ —

Summary
This report provides an overview of the pipeline landscape for sleep disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Restless Legs Syndrome, Nocturia and Insomnia, and features dormant and discontinued projects.

Restless Legs Syndrome is a neurologic disorder with a core feature of a distressing, irresistible need or urge to move the legs. Risk factors for RLS include low iron levels, kidney failure, Parkinson's disease, diabetes mellitus, rheumatoid arthritis, and pregnancy.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2385279-sleep-disorders-drug-development-pipeline-review-2017

Nocturia, or nocturnal polyuria, describes the excessive urination during night time. Nocturia becomes more common with age and may be symptomatic of the use of diuretic substances, prescription drugs, edema from heart failure, insomnia, pain and prostate or bladder disorders.

Finally, insomnia is a sleep disorder that is characterized by difficulty in falling or staying asleep. Symptoms include difficulty falling asleep at night, waking up during the night, irritability, depression and anxiety.

The size of these pipelines ranges from eight products in restless legs syndrome and nocturia to 31 in insomnia. Across all three of these indications there is a diverse range of molecular targets due to the different pathologies of the indications. The most common targets for restless legs syndrome, nocturia and insomnia therapeutics are D2 dopamine receptor, vasopressin V2 receptor and orexin receptor, respectively.

Scope
- Which companies are the most active within the pipeline for sleep disorder therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of sleep disorders?

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Content: Key Points

1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Sleep Disorders Report Coverage 7
2.2 Restless Legs Syndrome - Overview 7
2.3 Nocturia - Overview 7
2.4 Insomnia - Overview 7
3 Therapeutics Development 8
3.1 Restless Legs Syndrome 8
3.2 Nocturia 11
3.3 Insomnia 14
4 Therapeutics Assessment 21
4.1 Restless Legs Syndrome 21
4.2 Nocturia 27
4.3 Insomnia 33
5 Companies Involved in Therapeutics Development 39
5.1 Restless Legs Syndrome 39
5.2 Nocturia 42
5.3 Insomnia 44
6 Dormant Projects 53
6.1 Restless Legs Syndrome 53
6.2 Nocturia 53
6.3 Insomnia 54
7 Discontinued Products 56
7.1 Restless Legs Syndrome 56
7.2 Insomnia 56
8 Product Development Milestones 58
8.1 Restless Legs Syndrome 58
8.2 Nocturia 63
…Continued

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers
Phone: +91 841 198 5042

Source URL: https://marketersmedia.com/sleep-disorders-pharmaceutical-and-healthcare-pipeline-review-2017/250082

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 250082

More News From Daily World Feed

Former Indian PM Vajpayee dies after illness at age 93

Aug 17, 2018

NEW DELHI — Former Indian Prime Minister Atal Bihari Vajpayee, a Hindu nationalist who set off a nuclear arms race with rival Pakistan but later reached across the border to begin a groundbreaking peace process, died on Thursday after a prolonged illness. He was 93. The All India Institute of Medical Sciences, where Vajpayee had been hospitalized for more than two months for treatment of a kidney infection and chest congestion, announced his death. Vajpayee, a leader of the Hindu nationalist Bharatiya Janata Party, had suffered a stroke in 2009. A onetime journalist, Vajpayee was in many ways a political...

Chinese vice governor, mayor fired over vaccine scandal

Aug 17, 2018

BEIJING — A Chinese provincial deputy governor and the mayor of a major city were fired Thursday as the ruling Communist Party tried to defuse public outrage over revelations of misconduct by a major vaccine producer. The officials were among four people ordered dismissed following a meeting of the party's ruling Standing Committee led by President Xi Jinping. It ordered a criminal investigation of a fifth official, a former national drug regulator. The revelation in July that Changchun Changsheng Life Sciences Ltd. falsified production records for an anti-rabies vaccine added to a string of politically damaging scandals over deaths and...

Afghan IS branch claims deadly attack on Shiites in Kabul

Aug 17, 2018

KABUL, Afghanistan — As Afghanistan's Shiites mourned their dead and held funeral services Thursday, the Islamic State group claimed responsibility for the horrific suicide bombing in Kabul that targeted a Shiite neighborhood the previous day, killing 34 students. Grieving families gathered to bury their dead but even amid the somber atmosphere there was no respite from violence, underscoring the near-daily, persistent threats in the war-battered country. Two gunmen besieged a compound belonging to the Afghan intelligence service in a northwestern Kabul neighborhood early Thursday, opening fire as Afghan security forces moved in to cut them off. The standoff lasted for...

Myanmar panel probing Rohingya crisis pledges independence

Aug 17, 2018

NAYPYITAW, Myanmar — Members of a commission established by Myanmar's government to investigate human rights violations in western Rakhine state, where 700,000 members of the Muslim Rohingya minority fled brutal army operations, addressed critics Thursday with a pledge to be impartial. The Independent Commission of Enquiry held its first formal meeting Thursday in the capital, Naypyitaw, a day after holding talks with the country's leader, State Counsellor Aung San Suu Kyi. The commission's chairwoman, former Philippine diplomat Rosario Manolo, said at a news conference that the panel will be "independent, impartial and neutral." She said it will "seek accountability" and...

The Latest: Amnesty: Kabul attack on Shiites is 'war crime'

Aug 17, 2018

KABUL, Afghanistan — The Latest on developments in Afghanistan after a deadly suicide bombing in a Shiite area of Kabul (all times local): 5 p.m. Amnesty International says the suicide attack on Shiites in Kabul the day before that killed 34 students is a "war crime." Thursday's statement from the international rights group also decried the recent spike in violence in Afghanistan and the increasing number of civilians being killed. Samira Hamidi, Amnesty's South Asia campaigner, says "the deliberate targeting of civilians and the targeting of places of education is a war crime." She added that the "mounting civilian casualties...

About Us

Get yourself immersed in engaging topics right here. Daily World Feed is a multi-platform media, providing you latest breaking news straight from the industry.

Contact us: sales[at]dailyworldfeed.com

Subscribe Now!